Description
CD69, clone L78, is derived from hybridization of mouse Sp2/0-Ag14 myeloma cells with lymph node cells from BALB/c mice immunized with a CD8+ alloantigen–directed cytotoxic T-lymphocyte (CTL) cell line.
CD69 recognizes a very early human activation antigen that is a disulfide-bonded homodimer consisting of Mr 60-kilodalton (kd) polypeptides with one or two N-linked oligosaccharides.
Format
- FormatPurified
| Resources & Tools | ||||||
|---|---|---|---|---|---|---|
| SpectrumViewer | Download MSDS | Download TDS | ||||
Preparation and Storage
The monoclonal antibody is supplied as 100 μg purified immunoglobulin in 2.0 mL (50 μg/mL) of phosphate-buffered saline (PBS). The FITC conjugate is supplied as 100 μg in 2.0 mL (50 μg/mL) of PBS. The PE conjugate is supplied as 3.0 μg in 1.0 mL (3.0 μg/mL) of PBS. The PerCP conjugate is supplied as 50 μg in 1.0 mL (50 μg/mL) of PBS. The PE-Cy7 conjugate is supplied as 25 μg in 0.5 mL (50 μg/mL) of PBS. The APC conjugate is supplied as 100 μg in 0.5 mL (200 μg/mL) of PBS. PBS contains gelatin and 0.1% sodium azide.
Store vials at 2° to 8°C. Conjugated forms should not be frozen and should be protected from prolonged exposure to light. Each reagent is stable for the period shown on the bottle label when stored as directed.
